A Total of 1,007 Percutaneous Coronary Interventions Without Onsite Cardiac Surgery
Acute and Long-Term Outcomes
Henry H. Ting, MD, MBA, FACC*,*,
Ganesh Raveendran, MD*,
Ryan J. Lennon, MS ,
Kirsten Hall Long, PhD ,
Mandeep Singh, MBBS, FACC*,
Douglas L. Wood, MD, FACC*,
Bernard J. Gersh, MB, ChB, DPhil, FACC*,
Charanjit S. Rihal, MD, MBA, FACC* and
David R. Holmes, Jr, MD, FACC*
* Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
Department of Health Sciences Research, Division of Biostatistics, Mayo Clinic, Rochester, Minnesota
Department of Health Sciences Research, Division of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota

View larger version (15K):
[in a new window]
|
Figure 1 Kaplan-Meier curves relating treatment location to (A) survival and to (B) freedom from recurrent myocardial infarction (MI) or target vessel revascularization (TVR) for matched patients undergoing elective percutaneous coronary intervention. ISJ = Immanuel St. Josephs HospitalMayo Health System; SMH = St. Marys Hospital.
|
|

View larger version (15K):
[in a new window]
|
Figure 2 Kaplan-Meier curves relating treatment location to (A) survival and to (B) freedom from recurrent myocardial infarction (MI) or target vessel revascularization (TVR) for matched patients undergoing primary percutaneous coronary intervention. ISJ = Immanuel St. Josephs HospitalMayo Health System; SMH = St. Marys Hospital.
|
|
|